期刊文献+

晚期直肠癌放疗后应用扶正抑瘤方及乌苯美司胶囊临床观察

下载PDF
导出
摘要 目的:观察晚期直肠癌放疗后应用扶正抑瘤方及乌苯美司胶囊的效果。方法:80例随机分为两组各40例。两组均在NCCN指南下行放化疗,放化疗后给予乌苯美司胶囊治疗,观察组加以扶正抑瘤方治疗。结果:总有效率观察组高于对照组(P<0.05)。治疗后两组Ig A、Ig G及CD4/CD8均明显升高,但观察组升高幅度更大(P<0.05)。治疗后两组KPS评分均明显下降(P<0.05),但观察组下降幅度更大(P<0.05)。结论:晚期直肠癌化疗后用扶正抑瘤方及乌苯美司胶囊疗效更佳,其机制可能与提高免疫功能及KPS评分有关。
出处 《实用中医药杂志》 2018年第8期955-956,共2页 Journal of Practical Traditional Chinese Medicine
  • 相关文献

参考文献4

二级参考文献62

  • 1Majid A Almadi,Nahla Azzam,Othman Alharbi,Alabbas H Mohammed,Nazia Sadaf,Abdulrahman M Aljebreen.Complications and survival in patients undergoing colonic stenting for malignant obstruction[J].World Journal of Gastroenterology,2013,19(41):7138-7145. 被引量:5
  • 2Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer[J]. N Engl J Med, 2004,350 ( 23 ) : 2335-2342.
  • 3Grothey A ,Sugrue MM,Purdie DM,et al. Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)[J]. J Clin Oncol, 2008,26 (33) :5326-5534.
  • 4Amado RG,Wolf M ,Peeters M ,et al. Wild-type KRAS is requi- red for panilumumab efficacy in patients with metastatic colorec- tal cancer[J]. J Clin Oncol, 2008,26 ( 10 ) : 1626-1634.
  • 5Karapetis CS,Khambata-Ford S,Jonker DJ,et al K-ras mutalions- and benefit from cetuximab in advanced colorectal cancer[J]. N Engl J Med ,2008,359(17) : 1757-1765.
  • 6Di Nicolantonio F, Martini M, Molinari F, et al, Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer[J]. J Clin Oncol, 2008.26 ( 35 ): 5705-5712.
  • 7Maughan TS, Adams RA, Smith CG ,et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treat- ment of advanced colorectal cancer:results of tire randomised phase 3 MRC COIN trial[J]. Lancet, 2011,377 ( 9783 ) : 2103-2114.
  • 8Debucquoy A,Haustermans K,Daemen A,et al. Molecular re- sponse to cetuximab and efficacy of preoperative cetuximabbas- ed chemoradiation in rectal cancer[J]. J Clin Oncol, 2009,27 ( 17 ) : 2751-2757.
  • 9Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluoronraeil,leucnvorin ,and ox- aliplatin(FOLFOX4)versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study[J]. J Clin Oncol. 2010,28 (31 ) :4697-4705.
  • 10Brouquet A,Mortenson MM,Vauthey JN,et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients:classic,combined or reverse strategy?[J]. J Am Coll Surg, 2010,210(5 ) : 934-941.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部